Pfizer's Xalkori drug was found to be effective against non-small-lung cancer patients with ROS1 gene abnormalities. The medicine decreased the size of tumors in 36 out of 50 patients with the rare disease.
Pfizer drug Xalkori effective against rare lung cancer in clinical trial
Tech Times - 29 Sep 2014 07:53
Pfizer's Xalkori drug was found to be effective against non-small-lung cancer patients with ROS1 gene abnormalities. The medicine decreased the size of tumors in 36 out of 50 patients with the rare disease.
Share this Article
Recommended